Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 395

1.

Quetiapine versus other atypical antipsychotics for schizophrenia.

Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S.

Cochrane Database Syst Rev. 2013 Nov 18;11:CD006625. doi: 10.1002/14651858.CD006625.pub3. Review.

PMID:
24249315
[PubMed - indexed for MEDLINE]
2.

Clozapine-associated asterixis: case report.

Kwak YT, Yang Y, Koo MS.

J Clin Psychopharmacol. 2014 Feb;34(1):165-7. doi: 10.1097/JCP.0b013e3182a5959b. No abstract available.

PMID:
24158019
[PubMed - indexed for MEDLINE]
3.

Aripiprazole augmentation for clozapine-associated tardive torticollis.

Huang WL, Chang HC, Tsai YF, Chang LR, Liu CM.

J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):E49. doi: 10.1176/appi.neuropsych.11110341. No abstract available.

PMID:
23224485
[PubMed - indexed for MEDLINE]
4.

Update on typical and atypical antipsychotic drugs.

Meltzer HY.

Annu Rev Med. 2013;64:393-406. doi: 10.1146/annurev-med-050911-161504. Epub 2012 Sep 27. Review.

PMID:
23020880
[PubMed - indexed for MEDLINE]
5.

Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis.

Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS.

Ann Intern Med. 2012 Oct 2;157(7):498-511. Review.

PMID:
22893011
[PubMed - indexed for MEDLINE]
6.

Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics.

Ferentinos P, Dikeos D.

Curr Opin Psychiatry. 2012 Sep;25(5):381-90. doi: 10.1097/YCO.0b013e3283568537. Review.

PMID:
22842659
[PubMed - indexed for MEDLINE]
7.

Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?

Attard A, Taylor DM.

CNS Drugs. 2012 Jun 1;26(6):491-508. doi: 10.2165/11632020-000000000-00000. Review.

PMID:
22668246
[PubMed - indexed for MEDLINE]
8.

Clozapine-induced stuttering: a case report and analysis of similar case reports in the literature.

Grover S, Verma AK, Nebhinani N.

Gen Hosp Psychiatry. 2012 Nov-Dec;34(6):703.e1-3. doi: 10.1016/j.genhosppsych.2012.02.010. Epub 2012 Apr 18. Review.

PMID:
22516217
[PubMed - indexed for MEDLINE]
9.

A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat.

Lim AL, Taylor DA, Malone DT.

J Psychopharmacol. 2012 Sep;26(9):1252-64. doi: 10.1177/0269881111430751. Epub 2012 Feb 23.

PMID:
22361477
[PubMed - indexed for MEDLINE]
10.

Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial.

Remington G, Kapur S, Foussias G, Agid O, Mann S, Borlido C, Richards S, Javaid N.

J Clin Psychopharmacol. 2012 Feb;32(1):95-9. doi: 10.1097/JCP.0b013e31823f913e.

PMID:
22198452
[PubMed - indexed for MEDLINE]
11.

Clozapine safety, 35 years later.

Raja M.

Curr Drug Saf. 2011 Jul;6(3):164-84. Review.

PMID:
22122392
[PubMed - indexed for MEDLINE]
12.

Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects.

Jafari S, Fernandez-Enright F, Huang XF.

J Neurochem. 2012 Feb;120(3):371-84. doi: 10.1111/j.1471-4159.2011.07590.x. Epub 2011 Dec 15. Review.

PMID:
22103329
[PubMed - indexed for MEDLINE]
13.

Atypical antipsychotic drugs in the treatment of Parkinson's disease.

Friedman JH.

J Pharm Pract. 2011 Dec;24(6):534-40. doi: 10.1177/0897190011426556. Epub 2011 Nov 17. Review.

PMID:
22095576
[PubMed - indexed for MEDLINE]
14.

Pharmacogenetics of response to antipsychotics in patients with schizophrenia.

Arranz MJ, Rivera M, Munro JC.

CNS Drugs. 2011 Nov 1;25(11):933-69. doi: 10.2165/11595380-000000000-00000. Review.

PMID:
22054119
[PubMed - indexed for MEDLINE]
15.

Treatment dilemma in comorbidity of schizophrenia and idiopathic Parkinson's disease.

Lan CC, Su TP, Chen YS, Bai YM.

Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):411.e3-5. doi: 10.1016/j.genhosppsych.2011.02.006. Epub 2011 Apr 1.

PMID:
21762841
[PubMed - indexed for MEDLINE]
16.

Tardive dyskinesia.

Aia PG, Revuelta GJ, Cloud LJ, Factor SA.

Curr Treat Options Neurol. 2011 Jun;13(3):231-41. doi: 10.1007/s11940-011-0117-x.

PMID:
21365202
[PubMed]
17.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

PMID:
21348048
[PubMed]
Books & Documents
18.

Genetics of antipsychotic-induced side effects and agranulocytosis.

Chowdhury NI, Remington G, Kennedy JL.

Curr Psychiatry Rep. 2011 Apr;13(2):156-65. doi: 10.1007/s11920-011-0185-3. Review.

PMID:
21336863
[PubMed - indexed for MEDLINE]
19.

Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.

Souza RP, Meltzer HY, Lieberman JA, Voineskos AN, Remington G, Kennedy JL.

Hum Psychopharmacol. 2011 Jan;26(1):21-7.

PMID:
21305610
[PubMed - indexed for MEDLINE]
20.

Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Masi G, Liboni F.

Drugs. 2011 Jan 22;71(2):179-208. doi: 10.2165/11585350-000000000-00000. Review.

PMID:
21275445
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk